Randomized study of adjuvant immunotherapy with autologous tumor cells and BCG in renal cancer

Ann N Y Acad Sci. 1993 Aug 12:690:367-9. doi: 10.1111/j.1749-6632.1993.tb44033.x.

Authors

E Galligioni¹, M Francini, M Quaia, A Carbone, A Spada, C Sacco, D Favaro, M Santarosa, G Carmignani, D Di Donna, et al.

Affiliation

¹ Gruppo Oncologico Cooperativo del Nord-Est (GOCCNE), Centro di Riferimento Oncologico, Aviano, Italy.

PMID: 8368758
DOI: 10.1111/j.1749-6632.1993.tb44033.x

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

BCG Vaccine
Carcinoma, Renal Cell / immunology
Carcinoma, Renal Cell / therapy*
Female
Humans
Hypersensitivity, Delayed / immunology
Immunotherapy, Active / methods*
Kidney Neoplasms / immunology
Kidney Neoplasms / therapy*
Male
Prospective Studies
Survival Analysis

Substances

BCG Vaccine